Our New York office, the firm’s largest, is home to a multidisciplinary team representing virtually all of our practices and industry groups. We help an array of clients—from industry-leading multinationals to innovative newcomers—navigate new paths to growth in today’s complex, hyper-competitive environment.
AN INNOVATIVE LEGAL TEAM
We serve our clients as business advisors, helping them overcome critical challenges and take advantage of timely opportunities—from bet-the-company litigation to first-of-their-kind cross-border deals.
Recognized among the Top IP TeamsIAM Patent 1000 and Legal 500 US
Real Estate Practice Group of the YearLaw360
Ranked Top 10 Investigations PracticeGlobal Investigations Review
Represented Barclays as sole book runner and sole lead arranger in two senior notes offerings by Kronos Acquisition Holdings Inc. totaling US$1 billion and a new US$900 million senior secured term loan.
Represented Citigroup, BofA Securities, BMO Capital Markets, J.P. Morgan and RBC Capital Markets as joint book-running managers for Sun Communities, Inc.’s US$1.28 billion public offering of common stock in connection with the forward sale agreements and acquisition of Safe Harbor.
Secured Third Circuit appellate victory in issue of first impression for David Gibson, the former Chief Financial Officer of Wilmington Trust.
Advised Merck Animal Health on its acquisition of the U.S. rights to SENTINEL® FLAVOR TABS® and SENTINEL® SPECTRUM® Chews from Virbac for $400 million.
Paul Hastings Adds Premier Global Capital Markets and Public Company Advisory Partner
February 05, 2024
Eric Landau Named a National Lawyer in Real Estate at Connect CRE’s 2023 National Lawyers in Real Estate Awards
January 30, 2024
Five Paul Hastings Lawyers Named Among 2023 Bankruptcy Tax Specialists by Turnarounds & Workouts
August 07, 2023
Paul Hastings Advised Metals Acquisition Limited in Acquisition of CSA Copper Mine from Glencore for $1.1 Billion
June 23, 2023
Paul Hastings Advised SD Biosensor and SJL Partners in Acquisition of Meridian Bioscience
February 06, 2023